Pre-Treatment T-Cell Receptors (TCR) Repertoire in Non-Small Cell Lung Cancer (NSCLC) Patients Treated With Single Agent Immunotherapy

被引：0
|
作者：
Abed, A. [1 ]
Calapre, L. [2 ]
Bowyer, S. [3 ]
Millward, M. [4 ]
Gray, E. [2 ]
机构：
[1] Linear Clin Res, Oncol, Nedlands, WA, Australia
[2] Edith Cowan Univ, Med Sci, Joondalup, WA, Australia
[3] Sir Charles Gairdner Hosp, Dept Med Oncol, Nedlands, WA, Australia
[4] Linear Clin Res, Nedlands, WA, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
T-CR repertoire; Non-small cell lung cancer; Immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA12.04
引用
收藏
页码：S870 / S870
页数：1
相关论文
共 50 条
  • [41] Single-agent vinorelbine in the treatment of non-small cell lung cancer
    Wozniak, AJ
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 62 - 66
  • [42] The Utilization of Pre-Treatment Neutrophil to Lymphocyte Ratio as a Predictive Marker for Efficacy of Immunotherapy in Non-Small Cell Lung Cancer
    Preeshagul, Isabel
    Sullivan, Kevin
    Paul, Doru
    Seetharamu, Nagashree
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1325 - S1325
  • [43] Harmonization radiomics models to predict tumor response in non-small cell lung cancer (NSCLC) patients treated with immunotherapy
    Yadav, Monica
    Lee, Jeeyeon
    Kim, Peter Haseok
    Lee, Seyoung
    Um, Taegyu
    Lee, Salie
    Chuchuca, Maria Jose
    Djunadi, Trie Arni
    Chung, Liam Il-Young
    Yu, Jisang
    Rodrigues, Darren
    Gennaro, Nicolo
    Kim, Leeseul
    Nam, Myungwoo
    Oh, Youjin
    Yoon, Sungmi
    Shah, Zunairah
    Kim, Yuchan
    Hong, Ilene
    Jang, Jessica
    Kang, Grace
    Cho, Amy
    Lee, Soowon
    Hong, Timothy
    Nam, Cecilia
    Velichko, Yury S.
    Chae, Young Kwang
    CANCER RESEARCH, 2024, 84 (06)
  • [44] HLA-I heterozygosity and increased incidence of immune related toxicity among non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy
    Law, Ngie Chang
    Abed, Afaf
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 165 - 165
  • [45] HLA-I heterozygosity and increased incidence of immune related toxicity among non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy
    Law, N. C.
    Gray, E. S.
    Abed, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S391 - S392
  • [46] Advances in the Treatment of Non-Small Cell Lung Cancer: Immunotherapy
    Patel, Shetal A.
    Weiss, Jared
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 237 - +
  • [47] Benefit of immunotherapy (IT) in advanced non-small cell lung cancer (NSCLC) in elderly patients (EP)
    Corral de la Fuente, E.
    Barquin Garcia, A.
    Saavedra Serrano, C.
    Olmedo Garcia, M. E.
    Martin Huertas, R.
    Serrano Domingo, J. J.
    Albarr Anartahona, V.
    Gomez Rueda, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [48] Inferring the T cell repertoire dynamics in non-small cell lung cancer metastases
    Richard, Corentin
    Hessey, Sonya
    Naceur-Lombardelli, Cristina
    Veeriah, Selvaraju
    Nageswaran, Gayathri
    Hiley, Crispin
    Quezada, Sergio
    Chain, Benny
    Swanton, Charles
    Jamal-Hanjani, Mariam
    CANCER RESEARCH, 2024, 84 (06)
  • [49] Immunotherapy causing pneumonitis in a patient with non-small cell lung cancer (NSCLC)
    Li, Rui
    Lee, Gina
    El-Sherief, Ahmed
    BMJ CASE REPORTS, 2019, 12 (03)
  • [50] Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
    Chiu, Li-Chung
    Lin, Shu-Min
    Lo, Yu-Lun
    Kuo, Scott Chih-Hsi
    Yang, Cheng-Ta
    Hsu, Ping-Chih
    VACCINES, 2021, 9 (07)
12345